Series B financing – Discover Pharma

Welcome to Discover Pharma! Today is : July 30, 2026

Series B financing

Biotech & Pharma Business,Digital & Data,Drug Discovery & Development,Research & Development
Qureight raises $20 million to expand AI imaging platform into new lung and heart diseases
Qureight has raised $20 million in a Series B financing [...]

July 30, 2026
Biotech & Pharma Business,Digital & Data,Drug Discovery & Development,Research & Development
Qureight raises $20 million to expand AI imaging platform for clinical trials
Qureight has raised $20 million in a Series B financing [...]

July 29, 2026
Biotech & Pharma Business,Clinical & Regulatory,Pharmaceuticals and therapeutics,Research & Development
Claris Bio raises $118 million to advance potential first drug treatment for LSCD
Claris Biotherapeutics has raised $118 million in a Series B [...]

July 29, 2026
Biotech & Pharma Business,Pharmaceuticals and therapeutics,Therapeutic Areas
Kainova Therapeutics raises $32m CAD Series B to advance immuno-oncology and inflammation pipeline
Kainova Therapeutics has secured $32m CAD in a Series B [...]

May 5, 2026
Biotech & Pharma Business,Clinical & Regulatory,Drug Discovery & Development,Pharmaceuticals and therapeutics,Therapeutic Areas
NRG Therapeutics closes oversubscribed £50m series B to advance clinical data in Parkinson’s and proof of concept in ALS/MND
NRG Therapeutics Ltd, a neuroscience company developing treatments targeting mitochondrial [...]

May 5, 2026
Biotech & Pharma Business,Clinical & Regulatory,Therapeutic Areas
VIVES Partners joins Nuclidium AG’s €84M Series B Financing to advance copper-based radiopharmaceuticals
VIVES Partners, managing company of VIVES Funds, has joined a [...]

May 5, 2026

This website uses cookies and third party services. See our Cookie Policy and Privacy Policy pages for details. OK